Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
EpCAM in morphogenesis.
Trzpis M, Bremer E, McLaughlin PM, de Leij LF, Harmsen MC. Trzpis M, et al. Among authors: mclaughlin pm. Front Biosci. 2008 May 1;13:5050-5. doi: 10.2741/3063. Front Biosci. 2008. PMID: 18508569 Review.
Expression of EpCAM is up-regulated during regeneration of renal epithelia.
Trzpis M, McLaughlin PM, van Goor H, Brinker MG, van Dam GM, de Leij LM, Popa ER, Harmsen MC. Trzpis M, et al. Among authors: mclaughlin pm. J Pathol. 2008 Oct;216(2):201-8. doi: 10.1002/path.2396. J Pathol. 2008. PMID: 18702175
Cancer immunotherapy: insights from transgenic animal models.
McLaughlin PM, Kroesen BJ, Harmsen MC, de Leij LF. McLaughlin PM, et al. Crit Rev Oncol Hematol. 2001 Oct;40(1):53-76. doi: 10.1016/s1040-8428(00)00129-3. Crit Rev Oncol Hematol. 2001. PMID: 11578916 Review.
The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.
McLaughlin PM, Harmsen MC, Dokter WH, Kroesen BJ, van der Molen H, Brinker MG, Hollema H, Ruiters MH, Buys CH, de Leij LF. McLaughlin PM, et al. Cancer Res. 2001 May 15;61(10):4105-11. Cancer Res. 2001. PMID: 11358833
An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy.
McLaughlin PM, Kroesen BJ, Dokter WH, van der Molen H, de Groot M, Brinker MG, Kok K, Ruiters MH, Buys CH, de Leij LF. McLaughlin PM, et al. Cancer Immunol Immunother. 1999 Sep;48(6):303-11. doi: 10.1007/s002620050579. Cancer Immunol Immunother. 1999. PMID: 10473805
EpCAM homologues exhibit epithelial-specific but different expression patterns in the kidney.
Trzpis M, McLaughlin PM, Popa ER, Terpstra P, van Kooten TG, de Leij LM, Harmsen MC. Trzpis M, et al. Among authors: mclaughlin pm. Transgenic Res. 2008 Apr;17(2):229-38. doi: 10.1007/s11248-007-9141-8. Epub 2007 Oct 17. Transgenic Res. 2008. PMID: 17940847
Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer.
van der Gun BT, de Groote ML, Kazemier HG, Arendzen AJ, Terpstra P, Ruiters MH, McLaughlin PM, Rots MG. van der Gun BT, et al. Among authors: mclaughlin pm. Br J Cancer. 2011 Jul 12;105(2):312-9. doi: 10.1038/bjc.2011.231. Epub 2011 Jun 21. Br J Cancer. 2011. PMID: 21694727 Free PMC article.
The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context.
Gommans WM, van Eert SJ, McLaughlin PM, Harmsen MC, Yamamoto M, Curiel DT, Haisma HJ, Rots MG. Gommans WM, et al. Among authors: mclaughlin pm. Cancer Gene Ther. 2006 Feb;13(2):150-8. doi: 10.1038/sj.cgt.7700882. Cancer Gene Ther. 2006. PMID: 16096650
Biodistribution studies of epithelial cell adhesion molecule (EpCAM)-directed monoclonal antibodies in the EpCAM-transgenic mouse tumor model.
Kosterink JG, McLaughlin PM, Lub-de Hooge MN, Hendrikse HH, van Zanten J, van Garderen E, Harmsen MC, de Leij LF. Kosterink JG, et al. Among authors: mclaughlin pm. J Immunol. 2007 Jul 15;179(2):1362-8. doi: 10.4049/jimmunol.179.2.1362. J Immunol. 2007. PMID: 17617629
Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.
van der Gun BTF, Wasserkort R, Monami A, Jeltsch A, Raskó T, Ślaska-Kiss K, Cortese R, Rots MG, de Leij LFMH, Ruiters MHJ, Kiss A, Weinhold E, McLaughlin PMJ. van der Gun BTF, et al. Int J Cancer. 2008 Jul 15;123(2):484-489. doi: 10.1002/ijc.23476. Int J Cancer. 2008. PMID: 18398839
44 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback